Global Specialty Active Pharmaceutical Ingredients Sales Market Report 2021

1 Specialty Active Pharmaceutical Ingredients Market Overview

• 1.1 Specialty Active Pharmaceutical Ingredients Product Scope
• 1.2 Specialty Active Pharmaceutical Ingredients Segment by Type
  • 1.2.1 Global Specialty Active Pharmaceutical Ingredients Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Steroidal API
  • 1.2.3 Peptide API
  • 1.2.4 Carbohydrate API
  • 1.2.5 Small Molecule API
  • 1.2.6 High Potency AP
• 1.3 Specialty Active Pharmaceutical Ingredients Segment by Application
  • 1.3.1 Global Specialty Active Pharmaceutical Ingredients Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 CNS
  • 1.3.3 Cardiovascular
  • 1.3.4 Genitourinary/Hormonal Drugs
  • 1.3.5 Rheumatology
  • 1.3.6 Diabetes
  • 1.3.7 Oncology
  • 1.3.8 Others
• 1.4 Specialty Active Pharmaceutical Ingredients Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Specialty Active Pharmaceutical Ingredients Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Specialty Active Pharmaceutical Ingredients Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Specialty Active Pharmaceutical Ingredients Price Trends (2016-2027)

2 Specialty Active Pharmaceutical Ingredients Estimates and Forecasts by Region

• 2.1 Global Specialty Active Pharmaceutical Ingredients Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Specialty Active Pharmaceutical Ingredients Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2021)
• 2.3 Global Specialty Active Pharmaceutical Ingredients Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Specialty Active Pharmaceutical Ingredients Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Specialty Active Pharmaceutical Ingredients Estimates and Projections (2016-2027)
  • 2.4.2 Europe Specialty Active Pharmaceutical Ingredients Estimates and Projections (2016-2027)
  • 2.4.3 China Specialty Active Pharmaceutical Ingredients Estimates and Projections (2016-2027)
  • 2.4.4 Japan Specialty Active Pharmaceutical Ingredients Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Specialty Active Pharmaceutical Ingredients Estimates and Projections (2016-2027)
  • 2.4.6 India Specialty Active Pharmaceutical Ingredients Estimates and Projections (2016-2027)

3 Global Specialty Active Pharmaceutical Ingredients Competition Landscape by Players

• 3.1 Global Top Specialty Active Pharmaceutical Ingredients Players by Sales (2016-2021)
• 3.2 Global Top Specialty Active Pharmaceutical Ingredients Players by Revenue (2016-2021)
• 3.3 Global Specialty Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Specialty Active Pharmaceutical Ingredients as of 2020)
• 3.4 Global Specialty Active Pharmaceutical Ingredients Average Price by Company (2016-2021)
• 3.5 Manufacturers Specialty Active Pharmaceutical Ingredients Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Specialty Active Pharmaceutical Ingredients Market Size by Type

• 4.1 Global Specialty Active Pharmaceutical Ingredients Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Specialty Active Pharmaceutical Ingredients Price by Type (2016-2021)
• 4.2 Global Specialty Active Pharmaceutical Ingredients Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Specialty Active Pharmaceutical Ingredients Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Specialty Active Pharmaceutical Ingredients Price Forecast by Type (2022-2027)

5 Global Specialty Active Pharmaceutical Ingredients Market Size by Application

• 5.1 Global Specialty Active Pharmaceutical Ingredients Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Specialty Active Pharmaceutical Ingredients Price by Application (2016-2021)
• 5.2 Global Specialty Active Pharmaceutical Ingredients Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Specialty Active Pharmaceutical Ingredients Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Specialty Active Pharmaceutical Ingredients Price Forecast by Application (2022-2027)

6 North America Specialty Active Pharmaceutical Ingredients Market Facts & Figures

• 6.1 North America Specialty Active Pharmaceutical Ingredients Sales by Company
  • 6.1.1 North America Specialty Active Pharmaceutical Ingredients Sales by Company (2016-2021)
  • 6.1.2 North America Specialty Active Pharmaceutical Ingredients Revenue by Company (2016-2021)
• 6.2 North America Specialty Active Pharmaceutical Ingredients Sales Breakdown by Type
  • 6.2.1 North America Specialty Active Pharmaceutical Ingredients Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Specialty Active Pharmaceutical Ingredients Sales Breakdown by Type (2022-2027)
• 6.3 North America Specialty Active Pharmaceutical Ingredients Sales Breakdown by Application
  • 6.3.1 North America Specialty Active Pharmaceutical Ingredients Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Specialty Active Pharmaceutical Ingredients Sales Breakdown by Application (2022-2027)

7 Europe Specialty Active Pharmaceutical Ingredients Market Facts & Figures

• 7.1 Europe Specialty Active Pharmaceutical Ingredients Sales by Company
  • 7.1.1 Europe Specialty Active Pharmaceutical Ingredients Sales by Company (2016-2021)
  • 7.1.2 Europe Specialty Active Pharmaceutical Ingredients Revenue by Company (2016-2021)
• 7.2 Europe Specialty Active Pharmaceutical Ingredients Sales Breakdown by Type
  • 7.2.1 Europe Specialty Active Pharmaceutical Ingredients Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Specialty Active Pharmaceutical Ingredients Sales Breakdown by Type (2022-2027)
• 7.3 Europe Specialty Active Pharmaceutical Ingredients Sales Breakdown by Application
  • 7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)

8 China Specialty Active Pharmaceutical Ingredients Market Facts & Figures

• 8.1 China Specialty Active Pharmaceutical Ingredients Sales by Company
  • 8.1.1 China Specialty Active Pharmaceutical Ingredients Sales by Company (2016-2021)
  • 8.1.2 China Specialty Active Pharmaceutical Ingredients Revenue by Company (2016-2021)
• 8.2 China Specialty Active Pharmaceutical Ingredients Sales Breakdown by Type
  • 8.2.1 China Specialty Active Pharmaceutical Ingredients Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Specialty Active Pharmaceutical Ingredients Sales Breakdown by Type (2022-2027)
• 8.3 China Specialty Active Pharmaceutical Ingredients Sales Breakdown by Application
  • 8.3.1 China 248 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 248 Sales Breakdown by Application (2022-2027)

9 Japan Specialty Active Pharmaceutical Ingredients Market Facts & Figures

• 9.1 Japan Specialty Active Pharmaceutical Ingredients Sales by Company
  • 9.1.1 Japan Specialty Active Pharmaceutical Ingredients Sales by Company (2016-2021)
  • 9.1.2 Japan Specialty Active Pharmaceutical Ingredients Revenue by Company (2016-2021)
• 9.2 Japan Specialty Active Pharmaceutical Ingredients Sales Breakdown by Type
  • 9.2.1 Japan Specialty Active Pharmaceutical Ingredients Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Specialty Active Pharmaceutical Ingredients Sales Breakdown by Type (2022-2027)
• 9.3 Japan Specialty Active Pharmaceutical Ingredients Sales Breakdown by Application
  • 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Specialty Active Pharmaceutical Ingredients Market Facts & Figures

• 10.1 Southeast Asia Specialty Active Pharmaceutical Ingredients Sales by Company
  • 10.1.1 Southeast Asia Specialty Active Pharmaceutical Ingredients Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Specialty Active Pharmaceutical Ingredients Revenue by Company (2016-2021)
• 10.2 Southeast Asia Specialty Active Pharmaceutical Ingredients Sales Breakdown by Type
  • 10.2.1 Southeast Asia Specialty Active Pharmaceutical Ingredients Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Specialty Active Pharmaceutical Ingredients Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Specialty Active Pharmaceutical Ingredients Sales Breakdown by Application
  • 10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Specialty Active Pharmaceutical Ingredients Market Facts & Figures

• 11.1 India Specialty Active Pharmaceutical Ingredients Sales by Company
  • 11.1.1 India Specialty Active Pharmaceutical Ingredients Sales by Company (2016-2021)
  • 11.1.2 India Specialty Active Pharmaceutical Ingredients Revenue by Company (2016-2021)
• 11.2 India Specialty Active Pharmaceutical Ingredients Sales Breakdown by Type
  • 11.2.1 India Specialty Active Pharmaceutical Ingredients Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Specialty Active Pharmaceutical Ingredients Sales Breakdown by Type (2022-2027)
• 11.3 India Specialty Active Pharmaceutical Ingredients Sales Breakdown by Application
  • 11.3.1 India Specialty Active Pharmaceutical Ingredients Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Specialty Active Pharmaceutical Ingredients Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Specialty Active Pharmaceutical Ingredients Business

• 12.1 Sanofi
  • 12.1.1 Sanofi Corporation Information
  • 12.1.2 Sanofi Business Overview
  • 12.1.3 Sanofi Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Sanofi Specialty Active Pharmaceutical Ingredients Products Offered
  • 12.1.5 Sanofi Recent Development
• 12.2 Cambrex
  • 12.2.1 Cambrex Corporation Information
  • 12.2.2 Cambrex Business Overview
  • 12.2.3 Cambrex Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Cambrex Specialty Active Pharmaceutical Ingredients Products Offered
  • 12.2.5 Cambrex Recent Development
• 12.3 Almac
  • 12.3.1 Almac Corporation Information
  • 12.3.2 Almac Business Overview
  • 12.3.3 Almac Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Almac Specialty Active Pharmaceutical Ingredients Products Offered
  • 12.3.5 Almac Recent Development
• 12.4 Johnson Matthey
  • 12.4.1 Johnson Matthey Corporation Information
  • 12.4.2 Johnson Matthey Business Overview
  • 12.4.3 Johnson Matthey Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Johnson Matthey Specialty Active Pharmaceutical Ingredients Products Offered
  • 12.4.5 Johnson Matthey Recent Development
• 12.5 PolyPeptide
  • 12.5.1 PolyPeptide Corporation Information
  • 12.5.2 PolyPeptide Business Overview
  • 12.5.3 PolyPeptide Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 PolyPeptide Specialty Active Pharmaceutical Ingredients Products Offered
  • 12.5.5 PolyPeptide Recent Development
• 12.6 AmbioPharm
  • 12.6.1 AmbioPharm Corporation Information
  • 12.6.2 AmbioPharm Business Overview
  • 12.6.3 AmbioPharm Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 AmbioPharm Specialty Active Pharmaceutical Ingredients Products Offered
  • 12.6.5 AmbioPharm Recent Development
• 12.7 Avecia
  • 12.7.1 Avecia Corporation Information
  • 12.7.2 Avecia Business Overview
  • 12.7.3 Avecia Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Avecia Specialty Active Pharmaceutical Ingredients Products Offered
  • 12.7.5 Avecia Recent Development
• 12.8 ST Pharm
  • 12.8.1 ST Pharm Corporation Information
  • 12.8.2 ST Pharm Business Overview
  • 12.8.3 ST Pharm Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 ST Pharm Specialty Active Pharmaceutical Ingredients Products Offered
  • 12.8.5 ST Pharm Recent Development
• 12.9 Biospring
  • 12.9.1 Biospring Corporation Information
  • 12.9.2 Biospring Business Overview
  • 12.9.3 Biospring Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Biospring Specialty Active Pharmaceutical Ingredients Products Offered
  • 12.9.5 Biospring Recent Development

13 Specialty Active Pharmaceutical Ingredients Manufacturing Cost Analysis

• 13.1 Specialty Active Pharmaceutical Ingredients Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Specialty Active Pharmaceutical Ingredients
• 13.4 Specialty Active Pharmaceutical Ingredients Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Specialty Active Pharmaceutical Ingredients Distributors List
• 14.3 Specialty Active Pharmaceutical Ingredients Customers

15 Market Dynamics

• 15.1 Specialty Active Pharmaceutical Ingredients Market Trends
• 15.2 Specialty Active Pharmaceutical Ingredients Drivers
• 15.3 Specialty Active Pharmaceutical Ingredients Market Challenges
• 15.4 Specialty Active Pharmaceutical Ingredients Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List